Vaccine-linked chemotherapy induces IL-17 production and reduces cardiac pathology during acute Trypanosoma cruzi infection
Abstract Chagas disease resulting from Trypanosoma cruzi infection leads to a silent, long-lasting chronic neglected tropical disease affecting the poorest and underserved populations around the world. Antiparasitic treatment with benznidazole does not prevent disease progression or death in patient...
Guardado en:
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/7d8ab2248bad4bc78f23356c1341a291 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:7d8ab2248bad4bc78f23356c1341a291 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:7d8ab2248bad4bc78f23356c1341a2912021-12-02T14:06:11ZVaccine-linked chemotherapy induces IL-17 production and reduces cardiac pathology during acute Trypanosoma cruzi infection10.1038/s41598-021-82930-w2045-2322https://doaj.org/article/7d8ab2248bad4bc78f23356c1341a2912021-02-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-82930-whttps://doaj.org/toc/2045-2322Abstract Chagas disease resulting from Trypanosoma cruzi infection leads to a silent, long-lasting chronic neglected tropical disease affecting the poorest and underserved populations around the world. Antiparasitic treatment with benznidazole does not prevent disease progression or death in patients with established cardiac disease. Our consortium is developing a therapeutic vaccine based on the T. cruzi flagellar—derived antigen Tc24-C4 formulated with a Toll-like receptor 4 agonist adjuvant, to complement existing chemotherapy and improve treatment efficacy. Here we demonstrate that therapeutic treatment of acutely infected mice with a reduced dose of benznidazole concurrently with vaccine treatment – also known as “vaccine-linked chemotherapy”—induced a TH17 like immune response, with significantly increased production of antigen specific IL-17A, IL-23 and IL-22, and CD8 + T lymphocytes, as well as significantly increased T. cruzi specific IFNγ-producing CD4 + T lymphocytes. Significantly reduced cardiac inflammation, fibrosis, and parasite burdens and improved survival were achieved by vaccine-linked chemotherapy and individual treatments. Importantly, low dose treatments were comparably efficacious to high dose treatments, demonstrating potential dose sparing effects. We conclude that through induction of TH17 immune responses vaccine-linked chemotherapeutic strategies could bridge the tolerability and efficacy gaps of current drug treatment in Chagasic patients.Julio V. Cruz-ChanLiliana E. Villanueva-LizamaLeroy VersteegAshish DamaniaMaria José VillarCristina González-LópezBrian KeeganJeroen PolletFabian GusovskyPeter J. HotezMaria Elena BottazziKathryn M. JonesNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-13 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q Julio V. Cruz-Chan Liliana E. Villanueva-Lizama Leroy Versteeg Ashish Damania Maria José Villar Cristina González-López Brian Keegan Jeroen Pollet Fabian Gusovsky Peter J. Hotez Maria Elena Bottazzi Kathryn M. Jones Vaccine-linked chemotherapy induces IL-17 production and reduces cardiac pathology during acute Trypanosoma cruzi infection |
description |
Abstract Chagas disease resulting from Trypanosoma cruzi infection leads to a silent, long-lasting chronic neglected tropical disease affecting the poorest and underserved populations around the world. Antiparasitic treatment with benznidazole does not prevent disease progression or death in patients with established cardiac disease. Our consortium is developing a therapeutic vaccine based on the T. cruzi flagellar—derived antigen Tc24-C4 formulated with a Toll-like receptor 4 agonist adjuvant, to complement existing chemotherapy and improve treatment efficacy. Here we demonstrate that therapeutic treatment of acutely infected mice with a reduced dose of benznidazole concurrently with vaccine treatment – also known as “vaccine-linked chemotherapy”—induced a TH17 like immune response, with significantly increased production of antigen specific IL-17A, IL-23 and IL-22, and CD8 + T lymphocytes, as well as significantly increased T. cruzi specific IFNγ-producing CD4 + T lymphocytes. Significantly reduced cardiac inflammation, fibrosis, and parasite burdens and improved survival were achieved by vaccine-linked chemotherapy and individual treatments. Importantly, low dose treatments were comparably efficacious to high dose treatments, demonstrating potential dose sparing effects. We conclude that through induction of TH17 immune responses vaccine-linked chemotherapeutic strategies could bridge the tolerability and efficacy gaps of current drug treatment in Chagasic patients. |
format |
article |
author |
Julio V. Cruz-Chan Liliana E. Villanueva-Lizama Leroy Versteeg Ashish Damania Maria José Villar Cristina González-López Brian Keegan Jeroen Pollet Fabian Gusovsky Peter J. Hotez Maria Elena Bottazzi Kathryn M. Jones |
author_facet |
Julio V. Cruz-Chan Liliana E. Villanueva-Lizama Leroy Versteeg Ashish Damania Maria José Villar Cristina González-López Brian Keegan Jeroen Pollet Fabian Gusovsky Peter J. Hotez Maria Elena Bottazzi Kathryn M. Jones |
author_sort |
Julio V. Cruz-Chan |
title |
Vaccine-linked chemotherapy induces IL-17 production and reduces cardiac pathology during acute Trypanosoma cruzi infection |
title_short |
Vaccine-linked chemotherapy induces IL-17 production and reduces cardiac pathology during acute Trypanosoma cruzi infection |
title_full |
Vaccine-linked chemotherapy induces IL-17 production and reduces cardiac pathology during acute Trypanosoma cruzi infection |
title_fullStr |
Vaccine-linked chemotherapy induces IL-17 production and reduces cardiac pathology during acute Trypanosoma cruzi infection |
title_full_unstemmed |
Vaccine-linked chemotherapy induces IL-17 production and reduces cardiac pathology during acute Trypanosoma cruzi infection |
title_sort |
vaccine-linked chemotherapy induces il-17 production and reduces cardiac pathology during acute trypanosoma cruzi infection |
publisher |
Nature Portfolio |
publishDate |
2021 |
url |
https://doaj.org/article/7d8ab2248bad4bc78f23356c1341a291 |
work_keys_str_mv |
AT juliovcruzchan vaccinelinkedchemotherapyinducesil17productionandreducescardiacpathologyduringacutetrypanosomacruziinfection AT lilianaevillanuevalizama vaccinelinkedchemotherapyinducesil17productionandreducescardiacpathologyduringacutetrypanosomacruziinfection AT leroyversteeg vaccinelinkedchemotherapyinducesil17productionandreducescardiacpathologyduringacutetrypanosomacruziinfection AT ashishdamania vaccinelinkedchemotherapyinducesil17productionandreducescardiacpathologyduringacutetrypanosomacruziinfection AT mariajosevillar vaccinelinkedchemotherapyinducesil17productionandreducescardiacpathologyduringacutetrypanosomacruziinfection AT cristinagonzalezlopez vaccinelinkedchemotherapyinducesil17productionandreducescardiacpathologyduringacutetrypanosomacruziinfection AT briankeegan vaccinelinkedchemotherapyinducesil17productionandreducescardiacpathologyduringacutetrypanosomacruziinfection AT jeroenpollet vaccinelinkedchemotherapyinducesil17productionandreducescardiacpathologyduringacutetrypanosomacruziinfection AT fabiangusovsky vaccinelinkedchemotherapyinducesil17productionandreducescardiacpathologyduringacutetrypanosomacruziinfection AT peterjhotez vaccinelinkedchemotherapyinducesil17productionandreducescardiacpathologyduringacutetrypanosomacruziinfection AT mariaelenabottazzi vaccinelinkedchemotherapyinducesil17productionandreducescardiacpathologyduringacutetrypanosomacruziinfection AT kathrynmjones vaccinelinkedchemotherapyinducesil17productionandreducescardiacpathologyduringacutetrypanosomacruziinfection |
_version_ |
1718392029843554304 |